Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Treatment of Huntington's Chorea With Amantadine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating amantadine for Huntington's chorea has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine (amantadine)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Chorea, Huntington's Disease | Phase 2 | Status: COMPLETED